On the upside
VeriChip (Nasdaq: CHIP) and the Diabetes Research Institute entered a strategic partnership to develop a glucose-sensing radio frequency indentification microchip.
Third quarter earnings for Gentex (Nasdaq: GNTX) rose to top estimates and the auto parts maker forecast higher fourth quarter revenue.
While third quarter earnings slipped for Stryker (NYSE: SYK) due to lower shipments of its products, the results met expectations.
On the downside
European regulators will issue a negative opinion of Antigenics' (Nasdaq: AGEN) cancer vaccine Oncophage.
The South Financial Group (Nasdaq: TSFG) warned of significant losses for the third quarter as loan loss provisions soared.
American Airlines (NYSE: AMR) swung to a loss for the third quarter as revenue plunged.
In the broad market, advancing issues outpaced decliners by a margin of more than 2 to 1 on the NYSE and by more than 5 to 3 on Nasdaq. The Russell 2000 which tracks small cap stocks climbed 5 points to 618.
